Joslin Diabetes Center, The American Journal of Managed Care® Collaborate to Publish Clinical Guidelines
June 23 2018 - 9:00AM
Business Wire
Clinical guidelines that direct care at Joslin Diabetes
Center, the world-renowned institution for diabetes treatment,
research, and education, are now published in Evidence-Based
Diabetes Management™, a publication of The American
Journal of Managed Care®
The American Journal of Managed Care® has published core
clinical guidelines from Joslin Diabetes Center, the world-renowned
center for research, treatment, and education on a disease that now
affects 30.3 million people in the United States and more than 422
million worldwide.
Several pertinent chapters of the Guidelines are published in
the current issue of Evidence-Based Diabetes Management™ (EBDM™), a
publication of The American Journal of Managed Care® (AJMC®). These
chapters address care for adults with diabetes, nutritional
considerations for patients with diabetes, diabetes in pregnant
women, diabetes in the geriatric population, and pharmacological
treatment for adults with type 2 diabetes (T2D); recommendations
cover most topics that physicians, pharmacists, diabetes educators,
and other care providers will encounter in primary care practice.
The online version includes downloadable PDFs of the full issue and
individual chapters.
“At Joslin Diabetes Center, sharing our knowledge beyond the
clinic walls is central to our mission; we are committed to
impacting care globally,” said Robert A. Gabbay, MD, PhD, FACP,
senior vice president and chief medical officer at Joslin, who
serves as editor-in-chief for EBDM™. “As use of our Guidelines has
improved the quality of care for patients at Joslin and our
affiliates, we saw an opportunity to share that knowledge with
others who seek to better engage patients in the art of diabetes
self-management,” Dr. Gabbay said. “Publication of the Joslin
Clinical Guidelines in partnership with The American Journal of
Managed Care® allows us to reach physicians and managed care
opinion leaders who seek to achieve the best health outcomes for
people living with diabetes.”
Joslin’s Clinical Guidelines, which are developed and approved
by the Joslin Clinical Oversight Committee, have been in use for
years, but they were not in searchable formats. To publish the
Guidelines, Clinical Oversight Committee Chair Om P. Ganda, MD,
worked closely with the AJMC® editorial staff over a period of many
months.
First, Dr. Ganda worked with the Oversight Committee to produce
updated versions of each Guideline, including up-to-the-minute
recommendations in Pharmacological Management that reflect very
recent FDA approvals for new therapies to treat T2D. Then, Dr.
Ganda approved final versions of the Guidelines in a user-friendly
format. “As Chair of the Joslin Guidelines Committee, it has been
my privilege to lead the effort to create and periodically update
these concise and evidence-based guidelines over the past many
years. In this process, we have been fortunate to benefit from the
expertise and critical review by all members of the Committee and
working groups. It is now particularly gratifying to see their much
wider dissemination.”
Efforts are ongoing to promote use of the Joslin Clinical
Guidelines for diabetes management. “At The American Journal of
Managed Care®, we believe that continued learning is fundamentally
important, communication is key, and collaboration saves lives,”
said Jeff Prescott, PharmD senior vice president, Managed Markets.
“Our work with Joslin Diabetes Center to share their best
practices, which result in optimal clinical outcomes, is proof of
our commitment to this principle.”
About The American Journal of Managed
Care®:
The American Journal of Managed Care® (AJMC®) is a
peer-reviewed, MEDLINE-indexed journal that keeps readers on the
forefront of health policy by publishing research relevant to
industry decision makers as they work to promote the efficient
delivery of high-quality care. AJMC.com is the essential website
for managed care professionals, distributing industry updates daily
to leading stakeholders. Other titles in the AJMC® family
include The American Journal of Accountable Care®, and two
evidence-based series, Evidence-Based Oncology™
and Evidence-Based Diabetes Management™. These comprehensive
offerings bring together stakeholder views from payers, providers,
policymakers and other industry leaders in managed care. To order
reprints of articles appearing in AJMC® publications,
please contact Jeff Prescott, PharmD at 609-716-7777, ext. 331.
About Joslin
Joslin Diabetes Center is world-renowned for its deep expertise
in diabetes treatment, research and education. Joslin is dedicated
to finding a cure for diabetes and ensuring that people with
diabetes live long, healthy lives. We develop and disseminate
innovative patient therapies and scientific discoveries throughout
the world. Joslin is an independent, non-profit institution
affiliated with Harvard Medical School, and one of only 11
NIH-designated Diabetes Research Centers in the U.S. For more
information, visit www.joslin.org or follow @joslindiabetes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180623005023/en/
AJMC® Media:Theresa Burek,
609-716-7777tburek@mjhassoc.comorSurabhi
Vermasverma@mjhassoc.com